The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCK(B) receptor antagonist

Psychopharmacology

Volumn 131, Issue 1, 1997, Pages 79-85

  Valverde, Olga ^a   Smadja, Claire ^a   Roques, Bernard P ^a   Maldonado, Rafael ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CCK(B) receptor antagonist; Chronic unpredictable mild stress; Conditioned place preference; Depression; Imipramine; Morphine; PD 134,308; Reward; Stress

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; IMIPRAMINE; MORPHINE; OPIATE; SODIUM CHLORIDE; SUCROSE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONDITIONING; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MALE; MEGLUMINE; MORPHINE; RATS; RECEPTORS, CHOLECYSTOKININ; STRESS; TIME FACTORS;

EID: 0030988762     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050268     Document Type: Article

References (41)

1. Agmo A, Gömez M (1991) Conditioned place preference produced by infusion of Met-enkephalin into the medial preoptic area. Brain Res 550:343-346
2. Borsini F, Pulvirenti L, Samanin R (1985) Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in behavioural "despair" test in rats. Eur J Pharmacol 110: 253-256
3. Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516-517
4. Costello NL, Carlson JN, Click SD, Bryda M (1989) Dose-dependent and baseline-dependent conditioning with d-amphetamine in place preference paradigm. Psychopharmacology 99: 244-247
5. Crawley JN (1989) Microinjections of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion. Synapse 3:346-355
6. Crawley JN (1992) Subtype-selective cholecystokinin receptor antagonist block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathways. J Neurosci 12:3380-3391
7. Crawley JN, Hommer DW, Skirboll LK (1985) Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion. Brain Res 355:337-341
8. A receptors of the postero-medial part of nucleus accumbens. Pharmacol Biochem Behav 34:157-163
9. B antagonists in mice: antagonism by naltrindole. Br J Pharmacol 111:956-960
10. Gall C, Lauterborn J, Burks D, Seroogy K (1987) Co-localization of enkephalins and cholecystokinin in discrete areas of rat brain. Brain Res 403:403-408
11. Hawkins J, Hicks RA, Phillips N, Moore JD (1978) Swimming rats and human depression. Nature 274:512-513
12. Hernando F, Fuentes JA, Roques BP, Ruiz-Gayo M (1994) The CCK-B receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swin test in mice. Eur J Pharmacol 261:257-263
13. Higgins GA, Nguyen P, Seller EM (1992) Morphine place conditioning is differentially affected by CCK-A and CCK-B receptor antagonists. Brain Res 572:208-215
14. Hökfelt T, Rehfeld JF, Skirboll LR, Ivemark B, Goldstein M, Markey K (1980) Evidence for coexistence of dopamine and CCK in mesolimbic neurones. Nature 285:476-478
15. Hommer DW, Stoner G, Crawley JN, Paul SM, Skirboll LR (1986) Cholecystokinin-dopamine coexistence electrophysiological actions corresponding to cholecystokinin receptor subtype. J Neurosci 10:3039-3043
16. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN (1992) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728-6732
17. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, Kolakowski LF, Beinborn M (1992) Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89:3605-3609
18. Ladurelle N, Roques BP, Daugé V (1995) The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J Neurosci 15:3118-3127
19. Marshall FH, Barnes S, Hughes J, Woodruff GN, Hunter JC (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J Neurochem 10:3695-3700
20. Matthews K, Forbes N, Reid IC (1995) Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiol Behav 57:241-248
21. Moran TH, Robilson MS, Goldrich MS, McHugh PR (1986) Two brain cholecystokinin receptors for behavioural actions. Brain Res 362:175-179
22. Mucha RF, Van der Kooy D, O'Shoughnessy M, Bucenieks P (1982) Drugs reinforcement studied by use of place conditioning in rat. Brain Res 243:91-105
23. Muscat R, Towell A, Willner P (1988) Changes in dopamine autoreceptor sensitivity in an animal model of depression. Psychopharmacology 94:545-550
24. NIH (1985) Guide for the care and use of laboratory animals. Publication 85-23
25. Papp M, Willner P, Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104:255-259
26. Papp M, Lappas S, Muscat R, Willner P (1992) Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J Psychopharmacol 6:352-356
27. Papp M, Muscat R, Willner P (1993) Subsensitivity to rewarding and locomotor stimulant effects of dopamine agonist following chronic mild stress. Psychopharmacology 110:152-158
28. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441-446
29. 5-enkephalin-, and dynorphin A (1-8)-like material in the spinal cord and dorsal root ganglia of adult rats. Effects of dorsal rhizotomy and neonatal capsaicin. J Neurochem 55:1122-1130
30. 2 dopamine receptor. J Pharmacol Exp Ther 265:53-59
31. Smadja C, Maldonado R, Turcaud S, Fournié-Zaluski MC, Roques BP (1995) Opposite modulation of endogenous enkephalin antidepressant-like effects. Psychopharmacology 120:400-408
32. B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. J Pharmacol Exp Ther 270:77-88
33. B antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology 123:119-126
34. Wank SA, Pisegna JR, Weerth A (1992) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89:8691-8695
35. Wiertelak EP, Maier SF, Watkins LR (1992) Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science 256:830-833
36. Willner P (1990) Animal models of depression: an overview. Pharmacol Ther 45:425-455
37. Willner P, Towell A, Sampson D, Muscat R, Sophokleous S (1987) Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364
38. Willner P, Kliemek V, Golembiowska K, Muscat R (1991) Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 19:79-84
39. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534
40. Willner P, Moreau JL, Nielsen CK, Papp M, Sluzewska A (1996) Decrease hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol Behav 60:129-134
41. Wise RA (1980) Action of drugs of abuse on brain reward system. Pharmacol Biochem Behav 13:213-223